$250 Million is the total value of PURA VIDA INVESTMENTS, LLC's 92 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 148.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LIVN | New | LIVANOVA PLCcall | $19,465,000 | – | 195,000 | +100.0% | 7.80% | – |
| ATHN | New | ATHENAHEALTH INCcall | $11,538,000 | – | 72,500 | +100.0% | 4.62% | – |
| ICUI | New | ICU MED INCcall | $10,278,000 | – | 35,000 | +100.0% | 4.12% | – |
| XBI | New | SPDR SER TRput | $9,519,000 | – | 100,000 | +100.0% | 3.82% | – |
| IWM | New | ISHARES TRput | $7,370,000 | – | 45,000 | +100.0% | 2.95% | – |
| INSP | New | INSPIRE MED SYS INC | $7,142,000 | – | 200,280 | +100.0% | 2.86% | – |
| ICUI | Sell | ICU MED INC | $7,048,000 | -0.3% | 24,000 | -14.3% | 2.82% | -32.3% |
| LIVN | Sell | LIVANOVA PLC | $6,992,000 | +9.6% | 70,050 | -2.8% | 2.80% | -25.7% |
| BSX | New | BOSTON SCIENTIFIC CORPcall | $6,540,000 | – | 200,000 | +100.0% | 2.62% | – |
| CNC | New | CENTENE CORP DELcall | $6,161,000 | – | 50,000 | +100.0% | 2.47% | – |
| MTD | New | METTLER TOLEDO INTERNATIONALput | $5,786,000 | – | 10,000 | +100.0% | 2.32% | – |
| XLV | Sell | SELECT SECTOR SPDR TRput | $5,008,000 | -61.5% | 60,000 | -62.5% | 2.01% | -73.9% |
| NVRO | New | NEVRO CORPput | $4,791,000 | – | 60,000 | +100.0% | 1.92% | – |
| MDT | Buy | MEDTRONIC PLC | $4,281,000 | +25.6% | 50,000 | +17.6% | 1.72% | -14.8% |
| GWPH | New | GW PHARMACEUTICALS PLCcall | $4,186,000 | – | 30,000 | +100.0% | 1.68% | – |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $3,664,000 | – | 13,100 | +100.0% | 1.47% | – |
| QGEN | New | QIAGEN NVcall | $3,616,000 | – | 100,000 | +100.0% | 1.45% | – |
| SIEN | Sell | SIENTRA INC | $3,588,000 | +26.2% | 183,900 | -37.5% | 1.44% | -14.4% |
| HOLX | New | HOLOGIC INC | $3,478,000 | – | 87,500 | +100.0% | 1.39% | – |
| GMED | Sell | GLOBUS MED INCcl a | $3,406,000 | -49.4% | 67,500 | -50.0% | 1.36% | -65.6% |
| SPY | New | SPDR S&P 500 ETF TRput | $3,391,000 | – | 12,500 | +100.0% | 1.36% | – |
| ATHN | Sell | ATHENAHEALTH INC | $3,342,000 | -6.5% | 21,000 | -16.0% | 1.34% | -36.6% |
| AGN | Buy | ALLERGAN PLC | $3,334,000 | +98.1% | 20,000 | +100.0% | 1.34% | +34.4% |
| SYNH | New | SYNEOS HEALTH INCcl a | $3,283,000 | – | 70,000 | +100.0% | 1.32% | – |
| STAA | New | STAAR SURGICAL CO | $3,100,000 | – | 100,000 | +100.0% | 1.24% | – |
| GKOS | New | GLAUKOS CORPcall | $3,097,000 | – | 76,200 | +100.0% | 1.24% | – |
| VRAY | Buy | VIEWRAY INC | $2,999,000 | +10.5% | 433,315 | +2.7% | 1.20% | -25.0% |
| BAX | Sell | BAXTER INTL INC | $2,954,000 | -39.4% | 40,000 | -46.7% | 1.18% | -58.9% |
| SYNH | New | SYNEOS HEALTH INCcall | $2,814,000 | – | 60,000 | +100.0% | 1.13% | – |
| SPPI | Buy | SPECTRUM PHARMACEUTICALS INCcall | $2,739,000 | +70.2% | 130,700 | +30.7% | 1.10% | +15.5% |
| XENT | Sell | INTERSECT ENT INC | $2,715,000 | -37.2% | 72,500 | -34.1% | 1.09% | -57.4% |
| MYL | New | MYLAN NVcall | $2,711,000 | – | 75,000 | +100.0% | 1.09% | – |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $2,710,000 | – | 198,117 | +100.0% | 1.09% | – |
| XENT | New | INTERSECT ENT INCput | $2,622,000 | – | 70,000 | +100.0% | 1.05% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $2,549,000 | – | 15,000 | +100.0% | 1.02% | – |
| SIEN | Sell | SIENTRA INCcall | $2,447,000 | -49.7% | 125,400 | -75.1% | 0.98% | -65.9% |
| DXCM | Sell | DEXCOM INC | $2,375,000 | -13.8% | 25,000 | -32.7% | 0.95% | -41.5% |
| IVC | Sell | INVACARE CORP | $2,283,000 | -52.6% | 122,735 | -55.7% | 0.92% | -67.8% |
| GBT | New | GLOBAL BLOOD THERAPEUTICS INput | $2,260,000 | – | 50,000 | +100.0% | 0.91% | – |
| ARAY | Buy | ACCURAY INCcall | $2,255,000 | +50.3% | 550,000 | +83.3% | 0.90% | +2.0% |
| ZGNX | New | ZOGENIX INCcall | $2,210,000 | – | 50,000 | +100.0% | 0.89% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $2,115,000 | – | 16,000 | +100.0% | 0.85% | – |
| SPPI | New | SPECTRUM PHARMACEUTICALS INCput | $2,096,000 | – | 100,000 | +100.0% | 0.84% | – |
| GKOS | Buy | GLAUKOS CORP | $2,032,000 | +64.8% | 50,000 | +25.0% | 0.81% | +11.8% |
| ZGNX | Sell | ZOGENIX INC | $2,001,000 | -0.6% | 45,268 | -9.9% | 0.80% | -32.5% |
| HOLX | New | HOLOGIC INCcall | $1,988,000 | – | 50,000 | +100.0% | 0.80% | – |
| KIDS | New | ORTHOPEDIATRICS CORP | $1,982,000 | – | 74,385 | +100.0% | 0.79% | – |
| PRQR | New | PROQR THRAPEUTICS N V | $1,979,000 | – | 271,159 | +100.0% | 0.79% | – |
| WMGI | New | WRIGHT MED GROUP N V | $1,947,000 | – | 75,000 | +100.0% | 0.78% | – |
| CARA | New | CARA THERAPEUTICS INCcall | $1,915,000 | – | 100,000 | +100.0% | 0.77% | – |
| CSII | New | CARDIOVASCULAR SYS INC DELcall | $1,876,000 | – | 58,000 | +100.0% | 0.75% | – |
| MRK | Sell | MERCK & CO. INC | $1,821,000 | -66.6% | 30,000 | -70.0% | 0.73% | -77.3% |
| ZGNX | New | ZOGENIX INCput | $1,596,000 | – | 36,100 | +100.0% | 0.64% | – |
| CORT | New | CORCEPT THERAPEUTICS INCput | $1,575,000 | – | 100,200 | +100.0% | 0.63% | – |
| AXDX | New | ACCELERATE DIAGNOSTICS INCcall | $1,561,000 | – | 70,000 | +100.0% | 0.63% | – |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $1,557,000 | -24.7% | 550,000 | -5.9% | 0.62% | -48.9% |
| AVRO | New | AVROBIO INC | $1,499,000 | – | 52,500 | +100.0% | 0.60% | – |
| ADMA | New | ADMA BIOLOGICS INC | $1,466,000 | – | 325,000 | +100.0% | 0.59% | – |
| VRAY | New | VIEWRAY INCcall | $1,384,000 | – | 200,000 | +100.0% | 0.56% | – |
| CHRS | New | COHERUS BIOSCIENCES INCput | $1,365,000 | – | 97,500 | +100.0% | 0.55% | – |
| OBSV | New | OBSEVA SA | $1,363,000 | – | 90,000 | +100.0% | 0.55% | – |
| NVTRQ | Sell | NUVECTRA CORP | $1,334,000 | -8.9% | 65,000 | -42.2% | 0.54% | -38.2% |
| COLL | New | COLLEGIUM PHARMACEUTICAL INC | $1,245,000 | – | 52,219 | +100.0% | 0.50% | – |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $1,242,000 | -75.2% | 10,000 | -77.8% | 0.50% | -83.2% |
| IMMU | New | IMMUNOMEDICS INC | $1,193,000 | – | 50,400 | +100.0% | 0.48% | – |
| TTOO | New | T2 BIOSYSTEMS INC | $1,161,000 | – | 150,000 | +100.0% | 0.46% | – |
| ANGO | New | ANGIODYNAMICS INC | $1,131,000 | – | 50,842 | +100.0% | 0.45% | – |
| AKRXQ | New | AKORN INCcall | $1,126,000 | – | 67,900 | +100.0% | 0.45% | – |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $1,010,000 | -24.6% | 51,459 | -28.0% | 0.40% | -48.9% |
| CLLS | New | CELLECTIS S Aspon ads | $990,000 | – | 35,000 | +100.0% | 0.40% | – |
| VKTX | New | VIKING THERAPEUTICS INCput | $949,000 | – | 100,000 | +100.0% | 0.38% | – |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $818,000 | -65.8% | 25,000 | -71.4% | 0.33% | -76.8% |
| BLUE | New | BLUEBIRD BIO INC | $785,000 | – | 5,000 | +100.0% | 0.32% | – |
| FOLD | New | AMICUS THERAPEUTICS INCcall | $781,000 | – | 50,000 | +100.0% | 0.31% | – |
| MOTS | MOTUS GI HLDGS INC | $719,000 | +60.5% | 100,000 | 0.0% | 0.29% | +8.7% | |
| XENE | New | XENON PHARMACEUTICALS INC | $690,000 | – | 75,000 | +100.0% | 0.28% | – |
| GERN | New | GERON CORPput | $686,000 | – | 200,000 | +100.0% | 0.28% | – |
| INCY | Sell | INCYTE CORPcall | $670,000 | -59.8% | 10,000 | -50.0% | 0.27% | -72.7% |
| TGTX | TG THERAPEUTICS INC | $658,000 | -7.3% | 50,000 | 0.0% | 0.26% | -37.0% | |
| XNCR | New | XENCOR INC | $555,000 | – | 15,000 | +100.0% | 0.22% | – |
| STAA | New | STAAR SURGICAL COcall | $543,000 | – | 17,500 | +100.0% | 0.22% | – |
| EIGR | New | EIGER BIOPHARMACEUTICALS INC | $488,000 | – | 40,000 | +100.0% | 0.20% | – |
| CPRX | New | CATALYST PHARMACEUTICALS INC | $468,000 | – | 150,000 | +100.0% | 0.19% | – |
| GBT | New | GLOBAL BLOOD THERAPEUTICS INcall | $466,000 | – | 10,300 | +100.0% | 0.19% | – |
| VKTX | Sell | VIKING THERAPEUTICS INC | $447,000 | -41.5% | 47,100 | -73.1% | 0.18% | -60.3% |
| ITCI | New | INTRA CELLULAR THERAPIES INCcall | $442,000 | – | 25,000 | +100.0% | 0.18% | – |
| KMPH | New | KEMPHARM INC | $390,000 | – | 60,000 | +100.0% | 0.16% | – |
| ARDX | New | ARDELYX INC | $370,000 | – | 100,000 | +100.0% | 0.15% | – |
| ITCI | New | INTRA CELLULAR THERAPIES INC | $353,000 | – | 20,000 | +100.0% | 0.14% | – |
| OTIC | Sell | OTONOMY INC | $319,000 | -50.2% | 82,794 | -45.7% | 0.13% | -66.1% |
| CYTK | New | CYTOKINETICS INCcall | $204,000 | – | 24,600 | +100.0% | 0.08% | – |
| FOMX | FOAMIX PHARMACEUTICALS LTD | $121,000 | -2.4% | 24,100 | 0.0% | 0.05% | -34.2% | |
| VBLT | Exit | VASCULAR BIOGENICS LTDput | $0 | – | -100,000 | -100.0% | -0.14% | – |
| KALA | Exit | KALA PHARMACEUTICALS INCput | $0 | – | -15,000 | -100.0% | -0.14% | – |
| ARAY | Exit | ACCURAY INC | $0 | – | -88,958 | -100.0% | -0.26% | – |
| JNCE | Exit | JOUNCE THERAPEUTICS INC | $0 | – | -21,700 | -100.0% | -0.29% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO Lput | $0 | – | -20,000 | -100.0% | -0.30% | – |
| CHRS | Exit | COHERUS BIOSCIENCES INCcall | $0 | – | -50,000 | -100.0% | -0.33% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -5,000 | -100.0% | -0.33% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -59,600 | -100.0% | -0.34% | – |
| STDY | Exit | STEADYMED LTD | $0 | – | -215,214 | -100.0% | -0.41% | – |
| CLSD | Exit | CLEARSIDE BIOMEDICAL INC | $0 | – | -67,610 | -100.0% | -0.43% | – |
| ACER | Exit | ACER THERAPEUTICS INC | $0 | – | -41,795 | -100.0% | -0.48% | – |
| ARRY | Exit | ARRAY BIOPHARMA INCcall | $0 | – | -50,000 | -100.0% | -0.48% | – |
| AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -25,782 | -100.0% | -0.48% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -32,186 | -100.0% | -0.49% | – |
| EXEL | Exit | EXELIXIS INC | $0 | – | -40,000 | -100.0% | -0.52% | – |
| EOLS | Exit | EVOLUS INC | $0 | – | -102,544 | -100.0% | -0.55% | – |
| KALA | Exit | KALA PHARMACEUTICALS INC | $0 | – | -65,000 | -100.0% | -0.61% | – |
| CFMS | Exit | CONFORMIS INC | $0 | – | -731,041 | -100.0% | -0.63% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -15,000 | -100.0% | -0.74% | – |
| CSII | Exit | CARDIOVASCULAR SYS INC DEL | $0 | – | -67,000 | -100.0% | -0.87% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.89% | – |
| AGN | Exit | ALLERGAN PLCput | $0 | – | -10,000 | -100.0% | -0.99% | – |
| AMGN | Exit | AMGEN INCcall | $0 | – | -10,000 | -100.0% | -1.01% | – |
| NTUS | Exit | NATUS MED INC DEL | $0 | – | -57,620 | -100.0% | -1.14% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -1.17% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS INCput | $0 | – | -600,000 | -100.0% | -1.26% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -20,000 | -100.0% | -1.33% | – |
| QGEN | Exit | QIAGEN NV | $0 | – | -75,000 | -100.0% | -1.43% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INCput | $0 | – | -30,000 | -100.0% | -1.98% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -25,000 | -100.0% | -2.06% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -43,700 | -100.0% | -2.09% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -60,500 | -100.0% | -2.14% | – |
| INCY | Exit | INCYTE CORPput | $0 | – | -50,000 | -100.0% | -2.46% | – |
| CI | Exit | CIGNA CORPORATIONcall | $0 | – | -35,000 | -100.0% | -3.47% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB COcall | $0 | – | -100,000 | -100.0% | -3.74% | – |
| MRK | Exit | MERCK & CO. INCcall | $0 | – | -200,000 | -100.0% | -6.44% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-02-11
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICU MED INC | 26 | Q2 2023 | 4.2% |
| NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
| VIEWRAY INC | 25 | Q2 2023 | 3.2% |
| LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
| ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
| INVACARE CORP | 22 | Q3 2021 | 2.8% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
| INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
| ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
| ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
| Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
| Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
| Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
| MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
| INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
| MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
| TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| SC 13D/A | 2023-12-29 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.